Navigation Links
Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
Date:2/6/2008

echnologies' annual meeting of stockholders, as filed with the S.E.C. on a Schedule 14A. Information about the directors and executive officers of Tutogen and their ownership of Tutogen common stock is set forth in Tutogen's Annual Report on Form 10-K for the fiscal year ended September 30, 2007. Additional information regarding the interests of those participants and other persons who may be deemed participants in the merger may be obtained by reading the joint proxy statement/prospectus regarding the proposed merger filed with the S.E.C. on January 23, 2008. You may obtain free copies of these documents as described in the preceding paragraph.

Tutogen Medical, Inc.

Consolidated Statement of Income (Loss)

(In Thousands, Except for Share and Per Share Data)

Three Months Ended

December 31,

2007 2006

Revenue $ 14,955 $ 11,463

Cost of revenue 6,888 4,421

Gross profit 8,067 7,042

Operating Expenses

General and administrative 4,210 2,362

Distribution and marketing 4,553 3,441

Research and development 617 527

Total Operating Expenses 9,380 6,330

Operating (loss) income (1,313) 712

Foreign exchange loss (3) (38)

Interest and other income 130 34

Interest and other expense (86) (274)


'/>"/>

SOURCE Tutogen Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
6. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...
(Date:6/18/2013)... (Monday, June 17, 2013) A million electric cars could ... the decade with the help of research by the United ... University of Waterloo. , Professor Zhongwei Chen is part of ... to develop non-precious materials to replace the expensive platinum catalysts ... the adoption of fuel cells in vehicles is the cost ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 (PRWEB) June 18, 2013 ... time and attendance system in North America, has ... shares employee data and payroll records between ExakTime’s ... Plus automates ExakTime software setup and keeps ... imports employee data from a business’ current payroll ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 The human ... the skin as an important human body part. Similar to ... for in order to function, repair and grow. Recent reports ... vitamins and supplements, is just as important as other life ... supplements to aid in skin cell reproduction, increase the appearance ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2ExakTime Introduces AccountLinx Plus 2Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2
... LA JOLLA, Calif., Feb. 11 Cordex Pharma, Inc. ... a Medical Advisory Board to provide clinical guidance for ... of heart failure.The Medical Advisory Board will play an ... the planned CDP-1050 Phase 2 clinical trial and assist ...
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an ... for diseases caused by HIV-1 (Human Immunodeficiency Virus) ... McNally, Ph.D., Chief Executive Officer and President, presented ... CEO & Investor Conference 2009, held at the ...
... AMSTERDAM, The Netherlands, February 11, Agendia, a world ... of Alan B. Carter as the company,s new ... "As we continue to grow as ... primary aims," commented Dr. Bernhard Sixt, Ph.D., President ...
Cached Biology Technology:Cordex Pharma Forms Heart Failure Medical Advisory Board 2Cordex Pharma Forms Heart Failure Medical Advisory Board 3Cordex Pharma Forms Heart Failure Medical Advisory Board 4Cordex Pharma Forms Heart Failure Medical Advisory Board 5GeoVax Update Provided at the BIO CEO & Investor Conference 2009 2GeoVax Update Provided at the BIO CEO & Investor Conference 2009 3GeoVax Update Provided at the BIO CEO & Investor Conference 2009 4GeoVax Update Provided at the BIO CEO & Investor Conference 2009 5Agendia Appoints VP of Business Development 2
(Date:6/19/2013)... The PETA International Science Consortium (PISC) is extremely ... of Appeal has upheld a decision that requires ... study in rats. The study will use approximately ... unborn pups to the substance dipropylene glycol methyl ... the European Community,s Regulation on the Registration, Evaluation, ...
(Date:6/19/2013)... University of Pittsburgh has developed antibacterial compounds, derived ... be potential treatments for drug-resistant bacterial infections and ... are quite small, making them inexpensive and easy ... June 2013 issue of the journal Antimicrobial ... many probable applications will likely be the chronic ...
(Date:6/19/2013)... new variety of canary seeds bred specifically for human ... ideal for people with celiac disease (CD), scientists have ... of Agricultural and Food Chemistry . , Joyce ... 3 million people in the United States alone have ... wheat, barley, rye and other grains that contain gluten-related ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... Ore. The rearing of steelhead trout in hatcheries ... ability to reproduce in the wild, a new Oregon ... the wisdom of historic hatchery practices. The research, ... for the first time that the reproductive success of ...
... America (ESA) is proud to announce its selection of ... Selection as an ESA Fellow acknowledges outstanding contributions in ... who have have participated actively in ESA affairs and ... will be recognized during the ESA Annual Meeting, which ...
... worldwide and rank as number one in terms ... a recent ECNP commissioned report has demonstrated (Wittchen ... greatest decrement in health compared with the common ... (Moussavi et al., 2007) followed by addictive disorders ...
Cached Biology News:Salmonid hatcheries cause 'stunning' loss of reproduction 2Salmonid hatcheries cause 'stunning' loss of reproduction 3Entomological Society of America recognizes 2007 fellows and honorary members 2Entomological Society of America recognizes 2007 fellows and honorary members 320th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 220th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 320th ECNP Congress 2007, Oct. 13-17, Vienna, Austria 4